is syn stock a good buy

Ad DividendInvestor is an AwardWinning Dividend Screening Platform. The current consensus among 2 polled investment analysts is to Buy stock in Synthetic Biologics Inc.

Sizing Up Synthetic Biologics Nysemkt Syn Seeking Alpha

Synthetic Biologics stock price target cut to 150 from 250 at Maxim Group.

. Tired of hearing about other people getting rich in the stock market. He found Apple at 149. SYN Synthetic Biologics Inc Stock Price and Discussion Stocktwits.

Its typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. SYN Stock Analysis - Full Report SYN Chart by TradingView. This rating has held steady since November when it was unchanged from a Buy rating.

SYN stock quote history news and other vital information to help you with your stock trading and investing. As of August 08 2022 Synthetic Biologics Inc had a 230 million market capitalization putting it in the 14th percentile of companies in the Biotechnology Medical Research industry. Learn more on SYNs analyst rating history.

Sell transactions led buy transactions by 33 to 24. Ad Five tiny stocks have huge potential to reshape the next decade. Check out our SYN stock analysis current SYN quote charts and historical prices for Synthetic Biologics Inc stock.

11 Best Stocks to Buy for 2022. From Synthetic Biologics stock forecast Synthetic Biologics SYN stock can be a good investment choice. The companys sales are also soaring.

According to 6 analysts the average rating for SYN stock is Buy The 12-month stock price forecast is 1352 which is an increase of 80133 from the latest price. Our Top Picks For Stock Brokers. Find Todays Best Dividend Stocks Ex-dividend Dates and Stock Data.

17 2021 at 850 am. Trailing-12-month revenue is 67 billion up from about 54 billion in 2021 and close. 2 hours agoAutodesk saw 10 buy transactions but just seven sell transactionsA look at the last 12 months suggests a larger problem in the making.

Synthetic Biologics Inc stock has risen 2500 over the last 12 months and the average rating from Wall Street analysts is a Strong Buy. Currently Synthetic Biologics Incs price-earnings ratio is. The companys core work revolves around its proprietary DNA synthesis.

According to the issued ratings of 1 analysts in the last year the consensus rating for Synthetic Biologics stock is Buy based on the current 1 buy rating for SYN. Oracle at 051. That rank is influenced by a long-term technical score of 91.

The consensus among 1 Wall Street analyst covering NYSEMKT. In this case its the cash flow growth thats being looked at. Synthetic Biologics Inc NYSEMkt Updated Aug 23 2022 800 PM.

SYN 147 002 146 24031. SYN share price has been in a bear cycle for the past year. As an investor you want to buy stocks with the highest probability of success.

Out of 1 analyst 1 100 are recommending SYN as a Strong Buy 0 0 are recommending SYN as a Buy 0 0 are recommending SYN as a Hold 0 0 are recommending SYN as a Sell and. Find the latest Synthetic Biologics Inc. Is Synthetic Biologics Stock a good buy in 2022 according to Wall Street analysts.

That means you want to buy stocks with a Zacks Rank 1 or 2 Strong Buy or Buy which also has a Score of an A or a. Ad Beginner Experienced Investors Should Consider These Top-Recommended Stock Brokerages. InvestorsObservers proprietary ranking system gives SYN stock a score of 84 out of a possible 100.

In brief Twist is a leading name in the synthetic biology industry today. Five Under-The-Radar Investments You Cant Afford to Miss. According to AI Pickup the Synthetic Biologics stock price forecast for 2023 Jan.

Stock trend is negative. Ad Discover the time-tested tactics savvy investors use to build their wealth. 19 hours agoThats up from about 5 billion in 2021 and just 27 billion in 2020.

Synthetic Biologics Incs trailing 12-month revenue is 00 million with a profit margin. SYN stock is to Strong Buy SYN stock. From Novice To Expert Compare Brokers To Trade Stocks.

According to our research SYN stock is a bad long-term investment. ET by Tomi Kilgore. Starting us off today is Twist Biosciences.

The average twelve-month price prediction for Synthetic Biologics is 2250 with a high price target of 2250 and a low price target of 2250.

Syn Stock Price And Chart Amex Syn Tradingview

Close Up Of A Snow Leopard Panthera Uncia Syn Snow Leopard Panthera Animals

Syn Stock Price And Chart Amex Syn Tradingview

Synthetic Biologics Stock Forecast Down To 1 359 Usd Syn Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis

Synthetic Biologics Inc Common Stock Syn Stock Price Quote News History Nasdaq

Syn Stock Price And Chart Amex Syn Tradingview

Synthetic Biologics Inc Common Stock Syn Stock Price Quote News History Nasdaq

Synthetic Biologics Stock Forecast Down To 1 359 Usd Syn Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis